‘Completely preventable’ asthma deaths skyrocket by 32% The concerning trend saw 467 Australians die last year, but experts say most could have been avoided with the right safeguards in place.
Diabetes medication shortage worsens Access to treatment is becoming increasingly dire for patients, with GPs predicting a shortage of tirzepatide will add to an already long list of supply issues.
New asthma charts ‘very useful to have at one’s fingertips’ Updated medication charts will help curb complacency, overuse of available treatments, and keep management up to date, experts say.
RACGP responds to aged care medication reform While generally supportive of the performance outcomes and role of onsite pharmacists, the college says gaps remain in the framework.
Hypertension quadpill cost effective: Study A four-in-one high blood pressure pill would be an impactful and cost-effective addition to the Australian market, according to research.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
New advice for ‘unprecedented’ antibiotics shortage With ongoing supply issues, Therapeutic Guidelines has released a guide for prescribers on alternatives in the absence of first-line therapies.
Almost all blood pressure medications reduce migraine: Study The drugs could be used much more widely as an inexpensive preventive measure, new research suggests.
Does multimorbidity impact chronic disease treatment? New international research has looked into a range of chronic diseases and their potential impact on effectiveness of common medications.
RACGP moves to shore up wavering support for 60-day dispensing Amid reports of crossbenchers becoming wary of the reform, the college has co-signed an open letter outlining the expected benefits for both patients and the primary care system.